Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

BAUSCH HEALTH COMPANIES INC.

(BHC)
  Report
 SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Nyse
01/10/2022 01/11/2022 01/12/2022 01/13/2022 01/14/2022 Date
26.38(c) 27.76(c) 27.34(c) 26.75(c) 27.08(c) Last
3 583 600 12 505 502 5 064 479 3 234 541 4 539 901 Volume
-2.37% +5.23% -1.51% -2.16% +1.23% Change
More quotes
Estimated financial data (e) (USD)
Sales 2021 8 472 M - -
Net income 2021 -1 062 M - -
Net Debt 2021 20 649 M - -
P/E ratio 2021 -9,00x
Yield 2021 -
Sales 2022 8 818 M - -
Net income 2022 132 M - -
Net Debt 2022 19 237 M - -
P/E ratio 2022 33,1x
Yield 2022 -
Capitalization 9 731 M 9 731 M -
EV / Sales 2021 3,59x
EV / Sales 2022 3,29x
Nbr of Employees 21 600
Free-Float -
More Financials
Company
Bausch Health Companies Inc. is a specialty pharmaceutical and medical device company. The Company is engaged in developing, manufacturing, and marketing a range of branded, generic and branded generic pharmaceuticals, over-the-counter (OTC) products, and medical devices (contact lenses, intraocular lenses, ophthalmic surgical equipment and aesthetics devices), which are marketed directly or indirectly in over 100... 
Sector
Pharmaceuticals
Calendar
02/23Earnings Release
More about the company
Ratings of Bausch Health Companies Inc.
Trading Rating : 
Investor Rating : 
ESG Refinitiv : 
B
More Ratings
All news about BAUSCH HEALTH COMPANIES INC.
01/14Bausch + Lomb to list in U.S. and Canada, discloses revenue jump
RE
01/14NORTH AMERICAN MORNING BRIEFING : Stock Futures Muted Ahead of Bank Earnings
DJ
01/13BAUSCH HEALTH : + LOMB CORPORATION FILES REGISTRATION STATEMENT AND PRELIMINARY PROSPECTUS..
PU
01/13BAUSCH HEALTH COMPANIES INC. : Other Events (form 8-K)
AQ
01/13Bausch Health Companies Up 1.6% After Hours as It Files IPO Information With US, Canadi..
MT
01/13BAUSCH HEALTH BRIEF : Bausch + Lomb Corporation Files Registration Statement and Prelimina..
MT
01/13Bausch + Lomb Corporation Files Registration Statement and Preliminary Prospectus for P..
AQ
01/13Bausch & Lomb Incorporated has filed an IPO in the amount of $100 million.
CI
01/13Bausch Health Companies Inc. has filed an IPO.
CI
01/11Bausch Health Says Will Provide Business And Strategic Update At The 40th Annual J.P. M..
MT
01/11BAUSCH HEALTH BRIEF : Says Will Provide Business And Strategic Update At The 40th Annual J..
MT
2021Bausch Health Companies Inc. - RELISTOR (METHYLNALTREXONE BROMIDE) DATA IS PUBLISHED IN..
AQ
2021Bausch Health Companies Inc. Announces New Post-Hoc Analysis of Pooled Results on the S..
CI
2021Bausch Health Says Data From Post-Hoc Analysis Supports Use of Salix's RELISTOR for Pat..
MT
2021Bausch Health Companies Inc. - APMA Grants Seal of Approval for JUBLIA Topical Solution..
AQ
More news
News in other languages on BAUSCH HEALTH COMPANIES INC.
01/14Bausch + Lomb s'inscrit à la cote aux États-Unis et au Canada et annonce une hausse de ..
01/13Bausch & Lomb Incorporated a déposé une demande d'introduction en bourse pour un montan..
01/13Bausch Health Companies Inc. a déposé une demande d'introduction en bourse.
2021Bausch Health Companies Inc. annonce une nouvelle analyse post-hoc des résultats regrou..
2021Moody's révise la perspective de Bausch Health à négative ; baisse de 0,4 %.
More news
Analyst Recommendations on BAUSCH HEALTH COMPANIES INC.
More recommendations
Chart BAUSCH HEALTH COMPANIES INC.
Duration : Period :
Bausch Health Companies Inc. Technical Analysis Chart | BHC | CA0717341071 | MarketScreener
Technical analysis trends BAUSCH HEALTH COMPANIES INC.
Short TermMid-TermLong Term
TrendsBullishNeutralNeutral
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 10
Last Close Price 27,08 $
Average target price 33,70 $
Spread / Average Target 24,4%
EPS Revisions
Managers and Directors
Joseph C. Papa Chairman & Chief Executive Officer
Thomas J. Appio President & Co-Head-Bausch Lomb International
Sam Eldessouky CFO, Chief Accounting Officer, SVP & Controller
Tage Ramakrishna Chief Medical Officer, President-R&D
Robert N. Power Independent Director
Sector and Competitors
1st jan.Capi. (M$)
BAUSCH HEALTH COMPANIES INC.-1.92%9 731
JOHNSON & JOHNSON-1.35%441 855
ROCHE HOLDING AG-3.72%323 901
PFIZER, INC.-6.94%308 427
ABBVIE INC.0.35%240 202
ELI LILLY AND COMPANY-11.62%221 317